Non-Alcoholic Fatty Liver Disease Labs

NAFLD, now often called MASLD, may show mild ALT changes or normal enzymes. Learn which labs matter and what they cannot prove.

NAFLD lab results can be surprisingly quiet. Some people have mild ALT elevation. Others have liver enzymes inside the lab range. That does not make the condition imaginary, and it does not mean every abnormal liver enzyme is NAFLD. Blood tests help show patterns and risk. Imaging or biopsy is needed to confirm liver fat.

Overview

NAFLD is the older name for non-alcoholic fatty liver disease. Since 2023, the newer name is MASLD, metabolic dysfunction-associated steatotic liver disease. NASH is now called MASH. The terminology changed, but many lab reports and search results still use NAFLD.

MASLD means liver fat plus at least one cardiometabolic risk factor, such as overweight or obesity, blood sugar abnormality, high blood pressure, high triglycerides, or low HDL. Routine blood tests help monitor liver irritation, fibrosis risk, and metabolic context.

What These Results Usually Mean

The common early pattern is mild ALT elevation with ALT higher than AST. This differs from the classic alcohol-related pattern where AST can be higher than ALT. The difference is only a clue, not a diagnosis.

A substantial number of people with fatty liver have normal transaminases. Liver enzymes do not measure the amount of fat and do not reliably show fibrosis severity. MASH, which includes inflammation and liver-cell injury, cannot be separated from simple fatty liver by routine labs alone.

Normal Range

ALT and AST are reported in U/L. Traditional ALT reference ranges are often about 7 to 55 U/L. ACG guidance also describes lower true-normal upper limits: about 29 to 33 U/L for men and 19 to 25 U/L for women. Use the range printed on your own lab report.

For NAFLD or MASLD, normal range also includes the metabolic labs around the liver: glucose, HbA1c, triglycerides, HDL, plus platelets, bilirubin, albumin, PT/INR, ALP, and GGT.

What A High Result May Mean

Common contributors include excess visceral fat, insulin resistance, type 2 diabetes, high triglycerides, metabolic syndrome, rapid weight change, some medications, and alcohol exposure that needs to be separated from or considered alongside metabolic risk.

High ALT or AST may also reflect MASH, fibrosis, cirrhosis, viral hepatitis, alcohol-related liver disease, drug-related liver injury, autoimmune liver disease, or a bile-flow pattern when ALP, GGT, and bilirubin are involved. That is why NAFLD is not diagnosed from ALT alone.

What A Low Result May Mean

There is no low NAFLD lab value that proves the liver is clear. Normal ALT and AST can happen in fatty liver.

Low platelets, low albumin, or abnormal PT/INR are different. They can appear in more advanced chronic liver patterns, though they also have non-liver causes. Those findings deserve careful interpretation by a clinician.

Related Lab Tests To Check Together

ALT, AST, and the AST/ALT ratio are the usual starting point. FIB-4 combines age, AST, ALT, and platelets to screen for advanced fibrosis risk. AASLD recommends FIB-4 as an initial fibrosis risk tool in people with metabolic risk factors.

Bilirubin, albumin, PT/INR, ALP, and GGT help show whether the pattern is liver-cell, bile-flow, or synthetic-function related. Glucose, HbA1c, triglycerides, HDL, and blood pressure help define the metabolic side. Ultrasound, CT, MRI, CAP, FibroScan, VCTE, MRE, or biopsy may be used to assess liver fat or stiffness.

A useful way to think about NAFLD labs is that they monitor risk rather than name the disease by themselves. ALT and AST show liver-cell irritation. Platelets and FIB-4 help screen for advanced fibrosis risk. Albumin, bilirubin, and INR help show whether liver reserve is affected. Glucose, HbA1c, triglycerides, HDL, and blood pressure show the metabolic setting that often drives MASLD. The diagnosis still depends on evidence of liver fat, usually from imaging or biopsy.

It also helps to separate liver inflammation from liver reserve. ALT and AST can rise and fall quickly. Albumin, platelets, bilirubin, and INR tell a slower and often more serious story when they change together. That is why a doctor may be calm about a mild enzyme rise but more attentive when synthetic-function markers or platelet trends shift at the same time.

Why Trends Matter More Than One Result

A one-time ALT rise may reflect recent illness, alcohol, medication, supplement use, exercise, or another temporary factor. A repeated pattern is more useful. If ALT stays mildly high and metabolic markers are also abnormal, NAFLD or MASLD becomes a more focused discussion.

Fibrosis risk also changes over time. Watching FIB-4, platelets, albumin, bilirubin, and INR helps show whether the concern is simple enzyme irritation or possible chronic liver progression.

When To Talk With A Doctor

Talk with a doctor if imaging shows fatty liver, if ALT or AST stay elevated, if FIB-4 is 1.3 or higher, or if platelets, bilirubin, albumin, or INR are abnormal. Bring a list of medications, supplements, alcohol intake, and metabolic conditions.

Seek timely care for jaundice, dark urine, confusion, vomiting blood, black stools, new abdominal swelling, or severe abdominal pain.

Frequently Asked Questions

Is NAFLD the same as MASLD? NAFLD is the older term. MASLD is the newer term for metabolic dysfunction-associated steatotic liver disease.

Can NAFLD labs be normal? Yes. ALT and AST can be normal even when fatty liver is present.

What lab pattern is common in NAFLD? A common early pattern is mild ALT elevation with ALT higher than AST, but this is not specific.

Can blood tests diagnose NAFLD? No. Blood tests help with patterns and risk assessment, but imaging or biopsy confirms liver fat.

Can labs tell simple fatty liver from MASH? Routine labs alone cannot reliably separate simple fatty liver from MASH.

What is FIB-4 used for in NAFLD? FIB-4 screens for advanced fibrosis risk using age, AST, ALT, and platelets. It is not diagnostic by itself.

Which metabolic labs matter with NAFLD? Glucose, HbA1c, triglycerides, HDL, and blood pressure context matter because MASLD is tied to cardiometabolic risk.

Does normal ALT mean no fibrosis? No. Normal ALT is reassuring for active enzyme irritation, but it does not rule out fat or fibrosis.

How MediLens Helps Track This Over Time

MediLens lets you keep liver enzymes, platelets, FIB-4, bilirubin, albumin, INR, HbA1c, glucose, and lipids together. That makes NAFLD or MASLD monitoring less dependent on memory. You can show your doctor whether the pattern is stable or changing.

Key Takeaways

NAFLD is now commonly called MASLD; NASH is now MASH.
Fatty liver can exist with normal ALT and AST.
Routine blood tests cannot confirm liver fat or separate simple fatty liver from MASH.
FIB-4 helps screen for fibrosis risk but is not diagnostic.
Tracking liver and metabolic labs together gives the most useful picture.

This article is for general education, based on AASLD liver disease guidance and the ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. It is not a diagnosis or treatment advice and does not replace your doctor. Interpret results using the reference ranges on your own lab report and your physician's guidance.

A single lab result only tells part of the story. MediLens helps you scan lab reports, organize your results, compare changes over time, and better understand your long-term health trends.